FDA and Big Pharma – Speedbumps to Healing with Cannabis

Spike Bowan Blog Leave a Comment

Hurdle after hurdle, advocates for cannabis therapies have fought long and hard to bring the miracles and wonders that cannabis therapy can provide to light.

With tough opposition from the FDA, DEA, and big Pharmaceutical companies, the road has not been easy. Still Federally classified as a Schedule 1 drug, marijuana is highly looked down upon by Federal watch dogs. Meanwhile, States have exercised their rights to govern themselves, and have been passing legislation to allow for the advancement of CBD oil, Cannabis and Medical Marijuana.

This, I think, has pharmaceutical companies shaking in their boots and potentially feeling their wallets becoming a lot lighter.

Entrepreneur.com reports:

“People growing their own marijuana is a significant concern to Big Pharma. As state legalization of cannabis-derivatives spreads, the drug companies contemplating the potential of medical marijuana see a threat from both homegrown and professionally harvested medical-grade marijuana.

Pharma offers quality control and deep testing but experience shows that research and development adds to customer cost. Even the 21st Century Cures Act won’t speed up the famously slow pace of FDA drug approvals. Given the facts and the perception, you have to wonder if Big Pharma is for or against legalizing marijuana.

 You might consider the hypocrisy at the February 2014 meeting of the Community Anti-Drug Coalition of America (CADCA). While speaker after speaker preached against the legalization of marijuana, leading financial sponsors of the program included Purdue Pharma, the manufacturer of Oxycontin.” (Read More)

Big Pharma has deep pockets – pockets that rely on peoples’ dependence on their medications, and pockets they are willing to pay heavily to protect.

U.S. hospitals are treating far fewer opioid users in states that have legalized medical marijuana, a new study shows according to Fox News.

“Hospitalization rates for opioid painkiller dependence and abuse dropped on average 23 percent in states after marijuana was permitted for medicinal purposes, the analysis found. Hospitalization rates for opioid overdoses dropped 13 percent on average.

At the same time, fears that legalization of medical marijuana would lead to an uptick in cannabis-related hospitalizations proved unfounded, according to the report in Drug and Alcohol Dependence.”  (Read More)

An estimated 60 percent of Americans now live in the 28 states (and Washington, D.C.) where medical marijuana is legal under state law.

Meanwhile, the opioid epidemic – quadrupling in sales (since 1999) of prescription painkillers like Oxycontin and Vicodin – kills 91 Americans a day.

In a 2014 study, Dr. Marcus Bachhuber found deaths from opioid overdoses fell by 25 percent in states that legalized medical marijuana.

Sadly, an almost 50 year old Federal Law still blocks the path of Cannabis Saliva’s healing benefits across the country.

In 1970, a federal law put cannabis in the same category as heroin, Schedule 1 of the Comprehensive Drug Abuse Prevention and Control Act, and finds it has no medicinal value. This study was done almost 50 years ago! The bill vilified the potential for cannabis and prolonged ailments for countless thousands of people that could have been cured and treated. Rumor has it, that the bill was pushed by politicians who were being paid by pharmaceutical lobbyists who didn’t want their profit margins to decrease. Proof of this is sketchy at best.

The legalization of medical marijuana in an increasing number of U.S. states may be linked with a lower rate of use of other prescription drugs aside from opioids too. The researchers found that the rates of opioid use decreased in adults ages 21 to 40 in states with legalized medical marijuana where residents with prescriptions could obtain cannabis from dispensaries or grow their own, compared to states that had legalized medical marijuana but did not yet have an operational program for people to obtain it.

These speed bumps and hurdles on the road to healing WILL be overcome, much to Big Pharma’s chagrin.